Ghana's Scientists to Seek Commercial Approval for GE CowpeaOctober 28, 2020
Genetically engineered cowpea will be requested for commercial approval in Ghana in November, according to Savannah Agricultural Research Institute (SARI). SARI is one of the institutes of the Council for Scientific and Industrial Research that is tasked to develop enhanced crop varieties to help the farmers in the northern part of the country and beyond.
The Pod-borer resistant cowpea, which exhibits resistance to destructive Maruca pests, is currently undergoing an internal review process. Once this is done, the next step is to submit it to the National Biosafety Authority for environmental release. The Pod-borer resistant cowpea is expected to decrease spray from 10 times to 2 times only to control other pests that attack cowpea.
Read more from the Genetic Literacy Project.
You might also like:
- Nigeria Commercializes Pod Borer Resistant Cowpea, its First GM Food Crop
- Zambia to Release 2 Drought Tolerant Cowpea Varieties
- Scientists Engineer Cowpea to Produce Bt Protein Against Maruca Pod Borer
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- International Regulators, Tech Developers Share Experiences on Animal Biotech
- Ghana's Scientists to Seek Commercial Approval for GE Cowpea
- Thai Farmer Highlights Role of Biotech in Changing the Course of Agriculture
- UAE Passes Mandatory Biotech Labeling Law
- Scientists Find Gene for Slim Inflorescence Shape of Barley
- Research Team Finds Hormones Control Root Length
- Higher Income Nations See Harm in GM Food; Lower Income Countries Think they Help People
- Scientists Uncover Molecular Mechanisms in Drought Sensitivity of Rice
- Comprehensive Advancement in Plant Virus Resistance Due to Genetic Engineering
- Genome Editing Offers Solutions to GHG Emission Problems
- Initial Tests Show Arthritis Drug Does Not Treat COVID-19
- SARS-CoV-2 Uses Neuropilin-1 to Infect Human Cells
Read the latest:
- Biotech Updates (September 20, 2023)
- Gene Editing Supplement (September 13, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: